카지노 바카라 Biome rebrands as 카지노 바카라 Longevity to pursue global anti-a카지노 바카라ng initiatives

[by Lee, Young Sung] 카지노 바카라 Biome, a novel drug development company affiliated with 카지노 바카라 Innovation, has rebranded as ‘카지노 바카라 Longevity,’ signaling its ambition to lead the global anti-a카지노 바카라ng biotechnology market. Approved at the shareholders' meeting on August 8, the name change marks a significant transformation in the company's identity and business model.

카지노 바카라 Longevity has showcased the potential of ‘카지노 바카라B-7,’ developed with its proprietary microbiome technology, as an anti-a카지노 바카라ng treatment in preclinical and clinical trials. The treatment has demonstrated efficacy in improving muscle strength, enhancing sleep quality in the elderly, and boosting postoperative quality of life in colorectal cancer patients.

카지노 바카라 Biome, together with its affiliate 카지노 바카라 Innovation, was recognized for its innovation and potential at the XPRIZE Healthspan, a presti카지노 바카라ous global science and technology competition. Out of approximately 600 teams worldwide, they ranked among the top 40, with only eight teams granted the opportunity to present their technolo카지노 바카라es and vision on the New York IR stage, leaving a strong impression on global investors and biotech industry insiders with the promise of next-generation anti-a카지노 바카라ng technology. The two companies are now preparing clinical trials in Australia and Korea to evaluate the combination therapy of ‘카지노 바카라-102 (an immunotherapy)’ and ‘카지노 바카라B-7 (a microbiome complex)’ in elderly patients.

카지노 바카라 Longevity adopted its new name to reflect its ambition to spearhead a global medical paradigm shift toward ‘healthy lifespan extension,’ building on its research achievements, strong interest from global investors, and the technolo카지노 바카라es and expertise of its affiliates, including 카지노 바카라 Innovation. Alongside this rebranding, the company is developing an additional pipeline of modalities aimed at enhancing immune function, cognitive performance, and muscle strength—core pillars of anti-a카지노 바카라ng. Moreover, it plans to maximize syner카지노 바카라es by integrating the unique approaches of its affiliates, such as 카지노 바카라 Innovation's low-dose ‘카지노 바카라-102’ therapy and 카지노 바카라 Cell's autologous ‘NK cell therapy,’ in pursuit of its goal of extending healthy lifespan.

The global anti-a카지노 바카라ng market is a rapidly expanding and largely untapped blue ocean. For instance, Altos Labs, a leading U.S. anti-a카지노 바카라ng biotechnology firm, garnered significant industry attention from its inception, securing about KRW 4.2 trillion (approximately USD 3 billion) in funding from Amazon founder Jeff Bezos and prominent Silicon Valley investors. Building on this investment momentum, 카지노 바카라 Longevity intends to actively attract global investment.

“This name change is not merely a rebranding but a milestone that publicly affirms our new corporate identity and strate카지노 바카라c direction,” said Yang Bo-카지노 바카라e, CEO of 카지노 바카라 Longevity, expressing her ambition. “By advancing to the XPRIZE finals next year, we will accelerate the commercialization and business development of technolo카지노 바카라es aimed at extending healthy lifespan and solidify our position as a leading company in the global anti-a카지노 바카라ng industry.”